Showing results for "Stratasy"
technology
Apple Watch Series 9: Apple Tests 3D Printing in Device ProductionApple Inc. is testing the use of 3D printers to produce the steel chassis used by some of its upcoming smartwatches, according to people with knowledge of the matter, heralding a major change to how the company manufactures products.August 30, 2023
business
Biogen Makes Biggest M&A Bet to Date on Rare Diseases with Reata DealHi, it’s Michelle Davis in New York. Today, we’re putting the spotlight on a biotech deal that was announced this morning after we broke it. There’s also some cross-border deal news in mining and pharma. Have a great weekend! Today's top storiesJuly 28, 2023
business
AI Takes Center Stage at Allen & Co.’s Billionaire Summer CampHi there, it’s Kamaron Leach writing from an elevation of nearly 6,000 feet in Sun Valley, Idaho. Today, we chat AI, Bob Iger and ESPN at Allen & Co.’s summer camp for billionaires. We also look at what’s next for Lina Kahn and the FTC, and a big deal for Exxon.Today's top storiesJuly 13, 2023
business
JPMorgan’s Raghavan Sees Investment Banking Fees Rebounding to $70 BillionHi, it’s Ruth David in London, catching up with JPMorgan’s global co-head of investment banking. KKR also wins a bidding war and a Finnish credit information company explores a sale amid takeover interest. We're off Monday and Tuesday for the US holiday. See you Wednesday. Today's top storiesJune 30, 2023
business
An Dealmaking Slump That's Both Hard and Easy for Bankers to IgnoreHi, it’s Aaron Kirchfeld, Vinicy Chan and Kwaku Gyasi in London, reflecting on the bruising year so far for dealmakers. Elsewhere, a Goldman run comes to an end and a 30-year veteran of Credit Suisse leaves UBS. Today's top storiesJune 29, 2023
business
Top BofA Bankers Say M&A Has Hit Bottom and Is Poised to Bounce BackHi, it’s Matthew Monks in New York with Vinicy Chan and Swetha Gopinath in London. Welcome back after the US long weekend. Today we have some highlights from a Bank of America roundtable on global dealmaking. Plus Eli Lilly does a public biotech deal and Civitas gets serious in the Permian. Today's top storiesJune 20, 2023